跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 23,799 条关于
“Guardant360® CDx”
全部
23,799
临床试验
18,958
药物
1,889
机构
29
资讯
2,923
9个月前
Guardant Health Japan Secures First ESR1 Mutation Liquid Biopsy Approval for Breast Cancer Treatment Selection
去年
Two Phase III Trials Target Advanced Breast Cancer with Novel Therapeutic Approaches
去年
LeukoStrat® CDx FLT3 Mutation Assay Receives EU Approval for AML Treatment Selection
去年
FDA Approves FoundationOne CDx as Companion Diagnostic for Tovorafenib in Pediatric Low-Grade Glioma
去年
FDA Approves FoundationOne Liquid CDx as Companion Diagnostic for Itovebi in PIK3CA-Mutated Breast Cancer
去年
FDA Grants Priority Review to Telix's Pixclara for Brain Cancer Imaging
前天
Japan Approves FoundationOne CDx as Companion Diagnostic for Tovorafenib in BRAF-Altered Glioma
去年
Guardant Health Launches First Tissue Test with Comprehensive Multiomic Analysis for Cancer Profiling
去年
Invivoscribe's LeukoStrat CDx FLT3 Mutation Assay Receives Regulatory Approval in UK and Switzerland
去年
FDA Grants Priority Review to TLX101-CDx for Glioma Imaging
第 1 页,共 293 页
上一页
下一页